Form 4: Charles River Laboratories Executive VP Sells 4,400 Shares

Joseph W. LaPlume, EVP of Corporate Strategy & Development at Charles River Laboratories, sold 4,400 shares of common stock on February 20, 2025.

Summary

• On February 20, 2025, Joseph W. LaPlume, the Executive Vice President of Corporate Strategy & Development at Charles River Laboratories International, Inc., sold 4,400 shares of the company's common stock.
• The sale was executed at a price of $162.5 per share.
• Following the transaction, LaPlume directly owns 20,013 shares of Charles River Laboratories' common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to an insider stock sale. It doesn't inherently convey positive or negative sentiment, but the sale itself could be interpreted in various ways by the market.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity, which is common among corporate executives. It provides transparency to investors regarding the buying and selling of company stock by its officers.

Stakeholder Impact

• The stock sale by an executive could be perceived differently by shareholders; some might see it as a lack of confidence in the company, while others might view it as a personal financial decision.

Key Dates